Dutch researchers lead consortium on Organ-on-Chip development in Europe
Call to unite stakeholders and experts
Leiden University Medical Center and the Dutch
Organ-on-Chip consortium hDMT are now leading an EU initiative that
will establish a European infrastructure to enable coordinated
development, production and implementation of Organs-on-Chips by a
consortium of academic and private partners. In total six leading
European research institutions are involved.
The aim is to accelerate the societal and economic impact of Organ-on-Chip technology through coordinated action. Organs-on-Chips combine human mini-organs with microelectronics, microfluidics and nanosensors. This technology is already providing new platforms for drug discovery but is poised to deliver applications in personalized medicine and safety pharmacology, and offers alternatives to conventional animal testing. Over the next two years, the EU will invest 0.5 million Euros in the ORgan-on-CHip In Development (ORCHID) project.
ORCHID will facilitate dialogue and documentation towards accelerating the development of prototypes of Organs-on-Chips, validated cell systems that mimic diseased or healthy human tissue, and implementation of this technology by a broad group of potential users in science, health care and industry.
ORCHID will build an infrastructure for scientists, policy makers, funders and end-users to join the decision-making processes that will direct future European developments in Organ-on-Chip applications. An essential contribution of ORCHID will be the establishment of a digital platform enabling knowledge sharing between researchers and representatives of private corporations including insurance companies, pharmaceutical and biotech companies, food industry, health foundations and patient organizations.
The ORCHID platform will provide overviews and updates of current and new Organ-on-Chip initiatives so that users can track progress easily, consult developers directly and identify gaps in present knowledge, limiting implementation. ORCHID will also address ethical and regulatory issues, particularly concerning personalized information, economic and societal impact, training of researchers, and the design of an R&D 'roadmap'.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 766884
The consortium is composed of the following organizations:
- Leiden University Medical Center (the Netherlands):
contact: Christine Mummery, PhD, Professor of Developmental Biology, Chair Dept. of Anatomy
- Organ-on-Chip consortium hDMT (the Netherlands): strategy and
contact: Janny van den Eijnden van Raaij, PhD, Managing director
- Fraunhofer IGB (Germany): impact assessment, training,
contact: Peter Loskill, PhD, Attract Group Manager Organ-on-a-Chip, Department of Cell and Tissue Engineering
- CEA (France): eco-system development and the digital
contact: Adrienne Pervès PhD, Deputy Head of Department-LETI-Technologies for biology and health & Nathalie Picollet D'Hahan, PhD, Deputy Head Biomics Laboratory.
- imec (Belgium): ethical aspects, regulation and
contact: Wolfgang Eberle, PhD, Funded Program Manager Smart Health and NERF Coordinator EIT Health
- University of Zaragoza (Spain): dissemination
contact: Luis Fernandez, PhD, Professor at the Dept. of Mechanical Engineering, microfluidic leader of the Applied Mechanics and Bioengineering group
ORCHID kick-off meeting in Leiden (the Netherlands) on 19 October 2017
Standing (from left to right): Luis Fernandez (University of Zaragoza, Spain), Mart Graef (hDMT/TU Delft, the Netherlands)
Mieke Schutte (hDMT, the Netherlands), Christine Mummery (LUMC, the Netherlands), Janny van den Eijnden-van Raaij (hDMT, the Netherlands), Ellen Thomassen (LUMC, the Netherlands), Remco den Dulk (CEA, France), Dennis Doorakkers (LUMC, the Netherlands), Peter Loskill (Fraunhofer IGB, Germany).
Sitting (from left to right): Ignacio Ochoa (University of Zaragoza, Spain), Nathalie Picollet D'Hahan (CEA, France), Massimo Mastrangeli (hDMT/ TU Delft, The Netherlands), Dries Braeken (imec, Belgium)